By Judith Wenshuk, peptide research writer
Quick Answer: GLOW combines BPC-157, GHK-Cu, and TB-500 into a single vial focused on recovery and skin research, while KLOW takes the same three compounds and adds KPV. The choice between them comes down to whether your research interest includes the gut and inflammation research KPV is specifically studied for.
These are two of the most popular blends among Canadian researchers, and they’re closely related — which makes the difference between them easy to explain once you know what each component contributes.
What’s in GLOW
BPC-157 and TB-500 cover recovery and tissue-repair research, while GHK-Cu adds skin and anti-aging research to the mix — and is the reason reconstituted GLOW takes on a pale blue tint. Together, GLOW is built around recovery and skin research as a combined focus.
What’s in KLOW
KLOW is GLOW plus one addition: KPV, a peptide fragment studied specifically in inflammation and gut-health research contexts. If your research interest extends into that area, KLOW covers more ground in a single vial.
Which One Fits Your Goals
- Choose GLOW if your research focus is specifically recovery and skin — tendons, soft tissue, and skin/collagen research
- Choose KLOW if you also want inflammation and gut-health research covered in the same vial
Frequently Asked Questions
Is KLOW just a stronger version of GLOW? Not stronger — broader. It adds a fourth compound with a distinct research focus rather than increasing the amounts of the shared three.
Why is the reconstituted solution blue in both? That’s the GHK-Cu copper complex, present in both blends, and it’s completely normal.
Are GLOW and KLOW available in Canada? Yes — both blends are available through research peptide suppliers in Canada.
Leave a Reply